Table 4. Treatment-related complications in patients with surgically resected non-small cell lung cancer with or without idiopathic pulmonary fibrosis.

(A) Surgery-related complications
	LC with IPF (n = 96)	LC without IPF (n = 192)	P-value
Pneumonia	11 (11.5)	25 (13.0)	0.706
Pneumothorax	20 (20.8)	24 (12.0)	0.509
BPF	1 (1.0)	2 (1.0)	1.000
Prolonged MV	2 (2.1)	10 (5.2)	0.224
Arrythmia	1 (1.0)	2 (1.0)	1.000
Bleeding	2 (2.1)	3 (1.6)	0.751
ARDS*	2 (2.1)	2 (1.0)	0.255
AE–IPF	5 (5.2)	–
ARDS or AE–IPF	7 (7.3)	2 (1.0)	0.012
(B) Adjuvant treatment-related complication (n = 110)
Postoperative hospital day	10.2 ± 10.0	9.8 ± 11.9	0.780
	LC with IPF (n = 30)	LC without IPF (n = 80)	P-value
Cytopenia	2 (6.7)	17 (21.2)	0.091
GI trouble	8 (26.7)	28 (35.0)	0.409
Pneumonia	6 (20.0)	6 (7.5)	0.071
Pneumonitis	1 (3.4)	1 (1.2)	0.469
AE–IPF	2 (6.7)	0 (0.0)	0.126

Values are expressed as number (%).

*ARDS other than AE-IPF

AE-IPF, acute exacerbation of idiopathic pulmonary fibrosis; ARDS, acute respiratory distress syndrome; BPF, bronchopleural fistula; GI, gastrointestinal; LC, lung cancer; MV, mechanical ventilation